{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:25:00Z","timestamp":1778617500391,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","award":["1S10OD028511-01"],"award-info":[{"award-number":["1S10OD028511-01"]}],"id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002721","name":"Charcot-Marie-Tooth Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-ES032673"],"award-info":[{"award-number":["U01-ES032673"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS119678"],"award-info":[{"award-number":["R01-NS119678"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM127087"],"award-info":[{"award-number":["R35GM127087"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31AG090013-0 1"],"award-info":[{"award-number":["F31AG090013-0 1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM007347"],"award-info":[{"award-number":["T32GM007347"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymthe.2025.11.026","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:59:27Z","timestamp":1763657967000},"page":"1633-1651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL"],"prefix":"10.1016","volume":"34","author":[{"given":"Poorvi H.","family":"Dua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bazilco M.J.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara B.E.","family":"Marley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carissa M.","family":"Feliciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah L.","family":"Watry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quinn T.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Steury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abin","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin N.","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace D.","family":"Ramey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Capra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce R.","family":"Conklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9038-836X","authenticated-orcid":false,"given":"Luke M.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.11.026_bib1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.2022.13468","article-title":"Treatment of genetic diseases with CRISPR genome editing","volume":"328","author":"Kan","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2025.11.026_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.11.026_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","article-title":"Highly efficient therapeutic gene editing of human hematopoietic stem cells","volume":"25","author":"Wu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.11.026_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hum.2023.29263.bfs","article-title":"CASGEVY makes history as FDA approves first crispr\/cas9 genome edited therapy","volume":"35","author":"Philippidis","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.11.026_bib9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41591-019-0500-9","article-title":"Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss","volume":"25","author":"Gy\u00f6rgy","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.11.026_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.723023","article-title":"Allele-Specific Gene Editing Rescues Pathology in a Human Model of Charcot-Marie-Tooth Disease Type 2E","volume":"9","author":"Feliciano","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84065","article-title":"Allele-specific gene-editing approach for vision loss restoration in RHO-associated retinitis pigmentosa","volume":"12","author":"Liu","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2025.11.026_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102269","article-title":"Allele-specific CRISPR-Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy","volume":"35","author":"Bolduc","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.11.026_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/brain\/awg059","article-title":"Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease","volume":"126","author":"Jordanova","year":"2003","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.11.026_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.0000000000001773","article-title":"Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E","volume":"85","author":"Pisciotta","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2025.11.026_bib15","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/hmg\/ddu736","article-title":"Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype","volume":"24","author":"Adebola","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.026_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.expneurol.2018.06.010","article-title":"Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E","volume":"308","author":"Lancaster","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib17","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/hmg\/ddaf116","article-title":"Novel neurofilament light (Nefl) E397K mouse models of Charcot-Marie-tooth type 2E (CMT2E) present early and chronic axonal neuropathy","volume":"34","author":"P\u00e9rez-L\u00f3pez","year":"2025","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.026_bib18","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib19","article-title":"Abnormal neurofilament inclusions and segregations in dorsal root ganglia of a Charcot-Marie-Tooth type 2E mouse model","volume":"12","author":"Zhao","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2025.11.026_bib20","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/hmg\/ddh236","article-title":"Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models","volume":"13","author":"Perez-Olle","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.026_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-4159.2005.03095.x","article-title":"Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport","volume":"93","author":"P\u00e9rez-Oll\u00e9","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2025.11.026_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cm.21566","article-title":"Charcot-Marie-Tooth disease Type 2E\/1F mutant neurofilament proteins assemble into neurofilaments","volume":"76","author":"Stone","year":"2019","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.ymthe.2025.11.026_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nmd.2017.09.018","article-title":"A novel homozygous nonsense mutation in NEFL causes autosomal recessive Charcot-Marie-Tooth disease","volume":"28","author":"Fu","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.11.026_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.21728","article-title":"A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy","volume":"66","author":"Yum","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2014.10.005","article-title":"Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties","volume":"263","author":"Saporta","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/cpt.1718","article-title":"Human tridimensional neuronal cultures for phenotypic drug screening in inherited peripheral neuropathies","volume":"107","author":"Maciel","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.026_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71742-z","article-title":"Rapid, precise quantification of large DNA excisions and inversions by ddPCR","volume":"10","author":"Watry","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.11.026_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","article-title":"CRISPR\/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10","volume":"25","author":"Ruan","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.026_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.11.026_bib30","article-title":"Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR\/Cas9 Gene Editing","volume":"6","author":"Kaminski","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.11.026_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307814121","article-title":"Reversal of C9orf72 mutation-induced transcriptional dysregulation and pathology in cultured human neurons by allele-specific excision","volume":"121","author":"Sachdev","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.11.026_bib34","first-page":"4566","article-title":"Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.026_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"Crispr\/cas9 editing of the mutant huntingtin allele in vitro and in vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.026_bib36","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ymthe.2020.05.002","article-title":"Mutation-Independent Allele-Specific Editing by CRISPR-Cas9, a Novel Approach to Treat Autosomal Dominant Disease","volume":"28","author":"Christie","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.026_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16279-4","article-title":"Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders","volume":"7","author":"Christie","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.11.026_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/cpcb.51","article-title":"Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons","volume":"79","author":"Fernandopulle","year":"2018","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib39","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.11.026_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.11.026_bib41","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2025.11.026_bib42","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.cell.2023.08.041","article-title":"Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells","volume":"186","author":"Tsuchida","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.11.026_bib43","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib44","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ymthe.2020.11.009","article-title":"Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing","volume":"29","author":"Rabinowitz","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.026_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Carpenter","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nmeth.1653","article-title":"High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2025.11.026_bib47","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1038\/s41467-019-13212-3","article-title":"Ranking of non-coding pathogenic variants and putative essential regions of the human genome","volume":"10","author":"Wells","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.11.026_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cm.21676","article-title":"A review and analysis of the clinical literature on Charcot-Marie-Tooth disease caused by mutations in neurofilament protein L","volume":"78","author":"Stone","year":"2021","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.ymthe.2025.11.026_bib49","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.11.026_bib50","doi-asserted-by":"crossref","first-page":"D1313","DOI":"10.1093\/nar\/gkae1090","article-title":"ClinVar: updates to support classifications of both germline and somatic variants","volume":"53","author":"Landrum","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.11.026_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.141042","article-title":"Allele-specific silencing of the gain-of-function mutation in Huntington\u2019s disease using CRISPR\/Cas9","volume":"7","author":"Shin","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.11.026_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.11.026_bib53","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41588-019-0517-5","article-title":"The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy","volume":"51","author":"Lindeboom","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.11.026_bib54","article-title":"CRISPR tiling deletion screens reveal functional enhancers of neuropsychiatric risk genes and allelic compensation effects (ACE) on transcription","author":"Ren","year":"2024","journal-title":"bioRxiv."},{"key":"10.1016\/j.ymthe.2025.11.026_bib55","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","article-title":"Correction of a genetic disease in mouse via use of CRISPR-Cas9","volume":"13","author":"Wu","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2025.11.026_bib56","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nbt.3404","article-title":"Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition","volume":"33","author":"Kleinstiver","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib57","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41587-020-0587-z","article-title":"Publisher Correction: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing","volume":"38","author":"Kleinstiver","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aba8853","article-title":"Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants","volume":"368","author":"Walton","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.11.026_bib59","article-title":"Stable isotope labeling kinetics of neurofilament light in vitro and in vivo","author":"Leckey","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.ymthe.2025.11.026_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66058-3","article-title":"Characterizing and controlling CRISPR repair outcomes in nondividing human cells","volume":"16","author":"Ramadoss","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.11.026_bib61","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-019-09006-2","article-title":"CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations","volume":"10","author":"Cullot","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.11.026_bib62","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","article-title":"Large deletions induced by Cas9 cleavage","volume":"560","author":"Adikusuma","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.11.026_bib63","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib64","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.11.026_bib65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/humu.23412","article-title":"Variant pathogenicity evaluation in the community-driven Inherited Neuropathy Variant Browser","volume":"39","author":"Saghira","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2025.11.026_bib66","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.11.026_bib67","first-page":"119","article-title":"A robust method to derive functional neural crest cells from human pluripotent stem cells","volume":"2","author":"Kreitzer","year":"2013","journal-title":"Am. J. Stem Cells"},{"key":"10.1016\/j.ymthe.2025.11.026_bib68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nmeth.2840","article-title":"Isolation of single-base genome-edited human iPS cells without antibiotic selection","volume":"11","author":"Miyaoka","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2025.11.026_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/crispr.2021.0113","article-title":"Inference of CRISPR Edits from Sanger Trace Data","volume":"5","author":"Conant","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2025.11.026_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/cpmb.129","article-title":"Base Editing in Human Cells to Produce Single-Nucleotide-Variant Clonal Cell Lines","volume":"133","author":"Vasquez","year":"2020","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.11.026_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:10Z","timestamp":1778616430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625009657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525001625009657"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.026","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}